A paradigm shift in the understanding of GLP-1 receptor agonists, widely recognized as transformative agents in the battle against obesity…
Read More
The ‘forever drug’ assumption about GLP-1s may be wrong, according to nference analysis
A groundbreaking shift in the understanding of weight management outcomes following the cessation of GLP-1 agonist medications is emerging, challenging…
Read More
